Table 3.
Group | Sex | Age-years | Baseline eGFR mL/min/1.732 (serum Creatinine mg/dL) | Last on-treatment eGFR mL/min 1.732 (serum Creatinine mg/dL); months in the study | Last observed post-study drug eGFR mL/min 1.732 (serum Creatinine mg/dL) | Relevant history† |
---|---|---|---|---|---|---|
FTC-TDF | F | 55 | 119 (0.60) | 95 (0.9, a 1.5 fold increase in creatinine from baseline) at month 24 | 101 (0.75) | -No history of use of known nephrotoxic drugs within 1 month. Drug discontinuation based on creatinine clearance which was <50 mL/min) -Baseline serum phosphate: 2.7 mg/dL |
FTC-TDF | F | 38 | 127 (0.70) | 72 (1.03) at month 15 | 122 (0.71) | -Treated for upper respiratory tract infection with cephalosporin and fluconazole in proceeding 2 weeks - Creatinine fold change from baseline had resolved by 4 weeks after drug discontinuation (serum creatinine 0.78 mg/dL, eGFR 110 mL/min/1.732) |
TDF | F | 50 | 117 (0.70) | 55 (1.30) at month 6 | 98 (0.80) | -Pre-existing Cervical lesions with history of laparotomy and chronic use of analgesics including NSAID - eGFR was >90mL/min by 8 weeks after drug discontinuation, remained stable and non-progressive until exit |
TDF | M | 56 | 99 (0.98) | 57 (1.53) at month 30 | 78 (1.18) | -History of recent relocation to a hot and dry region -No urine dipstick protein /glucose -eGFR was 74 mL/min by 2 weeks after drug discontinuation |
TDF | F | 30 | 134 (0.7) | 98 (0.9) at month 18 | 110 (0.81) | Had ≥25% eGFR decline from baseline at month 18. Creatinine elevation grade was based on calculated creatinine clearance. Baseline weight=45 kg (BMI=24) |
Placebo | F | 40 | 93 (0.9) | 41 (1.78) at month 1 | 109 (0.78) | -Baseline weight=46 kg (BMI=19) -No urine dipstick protein/ glucose - eGFR was >60 mL/min within 8 weeks after drug discontinuation |
For the present analysis, eGFR was calculated from serum creatinine using the Chronic Kidney Disease Epidemiology Collaboration Equation, although the Cockcroft-Gault equation was used for safety monitoring during the study.
eGFR denotes estimated glomerular filtration rate, FTC denotes emtricitabine TDF denotes tenofovir disoproxil fumarate
All persons had normal serum phosphate at the last on-treatment visit.